This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Toxic effect of corrosive substances
ST19_TOXIC_EFFECT_CORROSIVE_SUBST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
189 |
4. Check minimum number of eventsNone |
189 |
5. Include endpointsNone |
189 |
6. Filter based on genotype QC (FinnGen only) |
189 |
Control definitions (FinnGen only)
- Control exclude
- ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T5[1-9]|T6[0-5]
- Name in latin
- Effectus toxicus substantiarum corrosivarum
Similar endpoints
↥List of similar endpoints to
Toxic effect of corrosive substances
based on the number of shared cases.
Similar with more cases:
- Toxic effects of substances chiefly nonmedicinal as to source
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 189 | 92 | 97 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | 43.05 | 40.30 | 45.66 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 169
- Matched controls
- 1689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T54.3
ICD-10 Finland
Toxic effect: Corrosive alkalis and alkali-like substances
2384.3
117.3
100
*
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
716.4
54.8
51
*
T54.2
ICD-10 Finland
Toxic effect: Corrosive acids and acid-like substances
+∞
39.1
36
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
20.3
27.7
42
27
T54.9
ICD-10 Finland
Toxic effect: Corrosive substance, unspecified
+∞
23.5
22
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
9.6
15.4
32
40
N05AH04
ATC
quetiapine; oral
4.7
14.9
59
174
N05AH03
ATC
olanzapine; systemic
7.6
14.9
36
58
T28.6
ICD-10 Finland
Corrosion of oesophagus
+∞
14.8
14
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.2
14.5
49
122
N05AA02
ATC
levomepromazine; systemic
12.5
13.5
24
22
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.0
13.0
62
215
T54.1
ICD-10 Finland
Toxic effect: Other corrosive organic compounds
+∞
12.7
12
*
N05AX08
ATC
risperidone; systemic
6.7
12.6
33
59
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.1
11.5
32
62
A02BC02
ATC
pantoprazole; systemic
3.1
10.9
111
650
N05BA06
ATC
lorazepam; systemic, sublingual
10.3
10.9
21
23
N03AG01
ATC
valproic acid; systemic, rectal
7.1
10.7
26
42
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.2
10.2
32
72
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.1
9.3
30
69
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.4
9.3
28
60
AA1AD
NOMESCO Finland
CT of head and brain
3.5
9.1
48
174
C07AA05
ATC
propranolol; systemic
3.5
9.0
45
157
N05BA01
ATC
diazepam; systemic, rectal
4.1
8.8
35
100
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
12.5
8.8
15
13
N05BA04
ATC
oxazepam; oral
3.1
8.7
56
233
N03AX09
ATC
lamotrigine; oral
6.5
8.6
22
38
N05AF03
ATC
chlorprothixene; systemic
9.3
8.5
17
20
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
15.5
8.3
13
9
N02BE01
ATC
paracetamol; systemic, rectal
3.5
8.3
148
1130
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
12.6
8.2
14
12
X78
ICD-10 Finland
Intentional self-harm by sharp object
35.2
8.2
10
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
9.2
8.0
16
19
N05CD07
ATC
temazepam; oral
4.8
7.8
26
62
N05AX12
ATC
aripiprazole; systemic
6.3
7.8
20
35
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
47.2
7.8
9
*
R11
ICD-10 Finland
Nausea and vomiting
4.5
7.6
27
69
N03AX16
ATC
pregabalin; oral
3.0
7.6
49
204
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.0
7.5
30
86
K22.2
ICD-10 Finland
Oesophageal obstruction
83.6
7.5
8
*
N05AN01
ATC
lithium; oral
11.6
7.4
13
12
X59
ICD-10 Finland
Exposure to unspecified factor
3.0
7.4
48
199
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.8
7.2
31
95
F60.9
ICD-10 Finland
Personality disorder, unspecified
12.8
7.2
12
10
N06AB03
ATC
fluoxetine; oral
3.9
7.1
29
85
N05CF01
ATC
zopiclone; oral
2.7
7.1
54
248
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
7.2
7.0
16
24
N03AE01
ATC
clonazepam; systemic
5.4
6.9
20
41
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
9.9
6.9
13
14
N06AX11
ATC
mirtazapine; oral
2.5
6.6
61
309
WX290
NOMESCO Finland
Other blockade of nerve
2.3
6.5
97
622
Z91.5
ICD-10 Finland
Personal history of self-harm
72.4
6.5
7
*
T26.6
ICD-10 Finland
Corrosion of cornea and conjunctival sac
72.4
6.5
7
*
P15
ICPC
Chronic alcohol abuse
8.7
6.5
13
16
UJD02
NOMESCO Finland
Gastroscopy
8.7
6.5
13
16
N03AX12
ATC
gabapentin; oral
3.4
6.5
31
104
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.8
6.3
17
32
N06AX16
ATC
venlafaxine; oral
3.2
6.3
35
129
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
18.9
6.3
9
5
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
18.9
6.3
9
5
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.1
6.3
24
66
S06.0
ICD-10 Finland
Concussion
3.5
6.3
29
94
SPAT1307
SPAT
Psychosocial counselling and guidance
3.8
6.3
26
77
Z72.8
ICD-10 Finland
Other problems related to lifestyle
27.8
6.3
8
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.5
6.2
29
95
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
70
299
3.13
12.15
5.0
4.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
24
7.19
10.35
3.1
4.8
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
13
16
8.65
9.85
4.2
2.9
mmol/l
2.1
1.7
0.49
13
16
(3021901) Oxygen saturation in Capillary blood
13
17
8.14
9.39
3.4
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
45
173
3.10
9.10
1.9
1.7
nmol/l
1187.8
1174.3
0.04
36
137
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
25
65
4.28
9.02
6.5
8.7
mmol/l
25.0
24.5
0.30
25
65
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
63
296
2.69
8.78
1.6
1.9
mg/l
0.6
1.0
1.91
42
209
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
46
186
2.95
8.48
2.3
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
81
439
2.48
8.32
11.4
8.5
inr
1.1
1.2
0.12
30
148
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
81
440
2.47
8.27
4.3
3.6
ng/l
41.7
36.6
0.07
53
258
(3015235) Bicarbonate [Moles/volume] in Capillary blood
15
27
5.95
8.16
4.6
2.2
mmol/l
24.9
24.8
0.04
15
21
(3019198) Lymphocytes [#/volume] in Blood
117
754
2.45
8.10
7.1
5.9
e9/l
1.9
1.9
0.51
104
679
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
78
420
2.46
8.08
4.5
2.8
u/l
53.0
55.4
0.36
73
389
(4198724)
11
14
8.28
8.07
3.9
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
225
2.66
7.46
4.3
3.0
ng/l
247.5
152.3
0.17
28
141
(3002030) Lymphocytes/100 leukocytes in Blood
110
708
2.32
7.39
7.4
5.8
%
28.9
28.9
0.00
104
676
(3001604) Monocytes [#/volume] in Blood
112
728
2.32
7.33
6.7
5.8
e9/l
0.6
0.6
0.62
97
650
(3018010) Neutrophils/100 leukocytes in Blood
109
703
2.30
7.23
7.3
5.5
%
56.9
56.3
0.18
104
669
(3006315) Basophils [#/volume] in Blood
112
731
2.31
7.22
7.1
5.8
e9/l
0.0
0.0
0.16
95
654
(3003396) Base excess in Arterial blood by calculation
34
127
3.05
7.14
6.5
9.1
mmol/l
0.9
1.1
0.10
28
100
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
88
528
2.25
6.85
6.5
5.9
mmol/l
1.2
1.2
0.50
83
487
(42870588) Differential panel, method unspecified - Blood
79
459
2.24
6.59
7.1
5.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
93
578
2.20
6.56
7.4
6.8
mmol/l
1.2
1.2
0.53
83
493
(3026008) Bacteria identified in Urine by Culture
64
343
2.31
6.46
4.0
2.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
37
155
2.72
6.28
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
112
758
2.17
6.27
7.9
6.1
e9/l
0.2
0.2
0.12
100
683
(3019069) Monocytes/100 leukocytes in Blood
104
687
2.14
6.16
8.0
6.0
%
8.1
8.5
0.67
99
653
(3028707) Methadone [Presence] in Urine by Screen method
18
49
3.95
6.08
9.1
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
56
290
2.32
6.07
2.5
2.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
13
27
5.10
6.07
4.5
4.4
kpa
8.9
9.6
0.59
13
27
(3013290) Carbon dioxide [Partial pressure] in Blood
13
27
5.10
6.07
4.5
4.4
kpa
5.2
5.0
0.43
13
27
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
77
455
2.17
6.06
3.9
3.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
83
508
2.13
5.94
4.3
3.6
u/l
36.4
33.6
0.13
77
480
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
24
81
3.25
5.93
4.4
2.6
kpa
5.5
5.0
1.38
24
74
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
76
3.31
5.88
4.3
2.8
mmol/l
2.9
0.9
1.64
16
57
(3037467) Urinalysis macro (dipstick) panel - Urine
132
972
2.19
5.71
4.9
3.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
102
683
2.07
5.68
7.6
5.7
%
2.5
2.8
0.82
96
643
(3018418) pH of Serum or Plasma
64
361
2.17
5.59
3.5
3.8
ph
7.4
7.4
0.42
18
65
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
132
2.71
5.58
2.2
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
79
3.18
5.53
8.8
3.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
127
2.72
5.47
2.2
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
142
1086
2.24
5.44
8.8
7.4
u/l
79.7
75.2
0.66
136
1018
(3009343) pH of Capillary blood
23
80
3.13
5.41
4.6
2.7
ph
7.4
7.4
—
7
6
(3022096) Basophils/100 leukocytes in Blood
99
664
2.03
5.40
8.0
5.7
%
0.7
0.7
0.05
93
623
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
75
456
2.07
5.35
1.9
1.7
pmol/l
90.3
98.8
0.89
38
245
(3000991) Gas panel - Venous blood
27
104
2.86
5.33
7.3
8.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
68
400
2.09
5.29
2.9
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
51
269
2.23
5.22
2.0
3.5
ng/l
484.5
717.3
0.82
42
226
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
11
23
5.02
5.08
16.5
13.2
nmol/l
1734.5
1618.1
0.12
11
23
(3026782) Osmolality of Urine
47
243
2.24
5.03
3.3
2.5
mosm/kgh2o
538.7
556.9
0.19
39
206
(3002582) Erythrocytes [#/volume] in Urine
67
399
2.05
5.00
4.1
2.8
e6/l
15.1
217.3
0.66
54
302
(3013650) Neutrophils [#/volume] in Blood by Automated count
118
862
1.98
4.85
12.2
9.3
e9/l
4.5
4.0
1.22
107
755
(3000850) Epithelial cells [#/volume] in Urine
49
266
2.14
4.62
3.0
2.5
e6/l
5.9
7.7
0.23
43
239
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
25
100
2.73
4.60
3.2
2.5
g/l
0.2
0.2
2.04
25
93
(3022145) Colonoscopy Study observation
33
152
2.42
4.58
1.4
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
142
1121
2.07
4.51
4.9
3.7
pmol/l
14.4
14.7
0.54
133
1036
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
31
4.07
4.33
1.2
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
93
646
1.87
4.26
5.8
3.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
98
698
1.84
4.10
4.4
3.2
estimate
0.0
0.0
0.00
25
127
(3021960) Folate [Moles/volume] in Serum or Plasma
49
278
2.03
4.08
1.4
1.3
nmol/l
17.2
21.5
1.85
44
241
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
82
554
1.85
4.05
4.7
3.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
54
323
1.94
3.85
5.1
3.3
kg/l
1.0
1.0
0.11
11
37
(3030467) Casts [#/volume] in Urine by Automated count
58
356
1.91
3.83
4.0
2.8
e6/l
0.2
0.5
0.76
43
262
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
61
2.96
3.80
10.4
12.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
96
694
1.78
3.70
5.7
4.4
estimate
0.0
0.0
0.00
26
131
(3019060) Gas panel - Arterial blood
19
74
2.74
3.68
4.6
4.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
71
470
1.82
3.68
4.6
3.3
e6/l
80.8
95.8
0.07
54
322
(3012544) pH of Venous blood
25
112
2.42
3.67
3.6
3.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
161
1371
2.18
3.63
6.2
4.2
mu/l
1.8
1.8
0.12
149
1276
(3009261) Glucose [Presence] in Urine by Test strip
97
707
1.76
3.61
4.5
3.2
estimate
0.0
0.0
0.00
23
125
(3040151) Glucose [Moles/volume] in Capillary blood
9
17
5.50
3.55
2.4
10.8
mmol/l
6.1
6.6
—
9
12
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
8
13
6.37
3.54
12.5
9.8
mmol/l
0.7
0.6
—
8
13
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
155
1307
2.03
3.51
5.1
4.7
mmol/mol
39.2
38.8
0.15
146
1243
(3014007) Fractional oxyhemoglobin in Arterial blood
17
64
2.82
3.50
8.1
12.9
%
94.3
93.8
0.19
17
64
(3015377) Calcium [Moles/volume] in Serum or Plasma
64
417
1.81
3.46
2.5
3.3
mmol/l
2.4
2.4
0.03
59
377
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
32
3.59
3.39
1.2
2.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
34
180
2.08
3.38
1.4
1.4
titre
493.3
459.5
—
6
39
(3044889) 12 lead EKG panel
124
981
1.77
3.37
5.1
3.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
63
413
1.79
3.32
4.6
2.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
91
2.47
3.31
8.1
2.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
33
174
2.09
3.31
2.2
2.2
umol/l
13.1
15.3
0.72
28
160
(3029937) Albumin [Presence] in Urine by Test strip
57
363
1.82
3.30
5.3
3.4
estimate
0.0
0.0
0.00
26
126
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
11
33
3.48
3.24
2.1
2.0
ug/l
0.5
0.8
0.31
11
33
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
20
4.67
3.15
1.2
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
108
2.29
3.05
7.9
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
173
1547
2.40
2.95
23.7
11.4
mg/l
23.4
22.8
0.09
144
1171
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
236
1.88
2.92
2.2
1.7
pmol/l
173529843.4
459.6
0.49
34
211
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
22
4.24
2.92
1.2
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
55
360
1.74
2.86
4.2
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
73
524
1.64
2.67
2.3
2.3
nmol/l
73.3
74.2
0.08
67
478
(3013512) EKG study
51
333
1.73
2.66
4.6
3.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
115
2.14
2.64
8.0
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
36
212
1.86
2.64
3.3
2.4
e6/l
1.1
0.7
0.31
20
112
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
46
293
1.75
2.61
2.3
1.9
mg/l
2.6
3.0
0.50
40
249
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
50
2.72
2.59
1.9
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
116
2.12
2.59
8.0
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
116
2.12
2.59
8.0
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
34
198
1.87
2.58
4.0
2.5
e6/l
3.0
2.3
0.19
19
97
(3002179) Metamyelocytes/100 leukocytes in Blood
21
103
2.17
2.53
4.0
4.3
%
1.1
0.5
—
7
22
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
26
3.58
2.51
1.2
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
45
2.78
2.50
2.3
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
31
177
1.90
2.49
2.3
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
112
2.09
2.42
5.5
4.4
%
1.4
0.8
—
8
35
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
71
2.37
2.42
1.8
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
85
646
1.57
2.40
3.1
2.5
ug/l
110.4
93.7
0.29
80
604
(3007853) Bacteria identified in Skin by Aerobe culture
29
164
1.91
2.40
2.5
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
8
6.38
2.38
2.4
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
22
114
2.05
2.32
8.3
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
27
151
1.92
2.31
2.3
2.2
%
21.8
26.3
0.81
20
125
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
93
2.16
2.31
2.1
2.3
u/l
15849.3
2425.1
—
6
40
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
13
4.73
2.29
1.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
42
2.72
2.22
2.2
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
50
340
1.64
2.22
6.3
6.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
13
55
2.46
2.17
3.6
2.4
mmol/l
25.1
24.0
0.75
13
50
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
14
4.39
2.17
1.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
25
3.29
2.12
1.1
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
26
3.17
2.04
1.3
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
57
2.38
2.02
2.1
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
134
1154
1.55
2.00
5.0
3.0
u/l
42.8
42.3
0.03
129
1106
(3021440) Promyelocytes/100 leukocytes in Blood
20
106
1.99
2.00
5.7
4.4
%
0.0
0.2
—
6
34
(3022217) INR in Platelet poor plasma by Coagulation assay
22
121
1.93
1.98
10.3
20.6
inr
1.1
1.3
—
9
21
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
21
3.42
1.98
1.0
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
15
71
2.21
1.98
3.0
2.3
e6/l
0.2
0.1
0.39
15
66
(40768441) Liver Pathology biopsy report
5
11
4.64
1.95
1.2
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
11
4.64
1.95
2.8
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
55
395
1.55
1.93
1.3
1.3
u/ml
1.9
1.3
0.28
13
106
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
93
2.03
1.92
1.6
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
17
86
2.07
1.92
1.1
1.1
—
6.2
—
0
5
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
17
3.61
1.85
1.0
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
83
658
1.47
1.80
13.8
8.6
e9/l
0.0
0.0
0.50
71
532
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
158
1427
1.65
1.79
18.1
9.9
ml/min/173m2
95.1
91.4
1.35
135
1137
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
9
36
2.57
1.76
1.6
1.5
nmol/l
0.5
0.4
—
9
27
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
18
3.41
1.76
1.2
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
27
166
1.73
1.73
3.4
3.0
umol/l
4.6
10.7
1.62
22
145
(3009508) Creatinine [Moles/volume] in Urine
55
405
1.50
1.70
5.1
3.1
mmol/l
9.0
8.6
0.18
48
350
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
157
1421
1.62
1.70
4.9
3.7
mmol/l
6.0
5.8
0.50
148
1327
(3011397) Hemoglobin [Presence] in Urine by Test strip
44
310
1.55
1.67
3.2
3.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
84
1.99
1.65
5.4
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
35
234
1.61
1.65
2.9
2.5
ug/g
122.3
122.6
0.00
28
187
(40760892) CBC W Ordered Manual Differential panel - Blood
51
372
1.51
1.65
5.9
5.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
122
1.81
1.62
7.2
2.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
14
3.64
1.62
1.2
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
57
2.18
1.59
1.1
3.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
165
1523
1.66
1.51
20.6
11.7
%
40.1
41.3
0.87
120
1251
(40768804) Tissue Pathology biopsy report
68
535
1.42
1.48
1.9
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
28
2.56
1.46
1.1
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
22
2.78
1.44
1.2
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
40
2.31
1.42
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
40
2.31
1.42
1.3
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
40
2.31
1.42
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
60
2.07
1.41
3.4
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
47
2.19
1.36
2.1
2.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
24
2.55
1.31
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
24
2.55
1.31
1.7
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
34
2.41
1.31
1.3
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
55
2.06
1.30
2.0
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
18
2.82
1.29
6.0
2.2
%
90.4
92.0
—
5
18
(3007164) IgA [Mass/volume] in Serum or Plasma
47
354
1.44
1.28
1.3
1.4
g/l
2.2
2.3
0.17
33
222
(40761511) CBC panel - Blood by Automated count
174
1642
1.75
1.27
21.7
10.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
141
0.48
1.27
1.6
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
101
1.75
1.24
6.2
4.4
%
0.0
0.0
—
5
26
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
162
1507
1.52
1.21
4.8
4.1
mmol/l
2.7
2.8
2.00
149
1415
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
10
50
2.06
1.19
1.3
2.2
g/l
1.4
1.3
—
10
44
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5
111
0.44
1.17
3.2
4.8
ug/l
2.1
7.8
—
5
91
(40761536) Microorganisms panel - Urine sediment
19
120
1.65
1.13
6.8
3.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
30
2.38
1.13
2.1
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
57
454
1.37
1.12
1.7
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
89
1.74
1.11
1.1
1.2
—
30.2
—
0
5
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
89
1.74
1.11
4.2
2.4
ml/min/173m2
93.3
74.4
—
8
36
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
46
2.00
1.05
1.3
1.3
—
—
—
0
0
(4010399)
16
99
1.67
1.04
1.7
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
256
0.63
1.01
1.5
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
16
100
1.66
1.00
2.0
2.3
—
19.4
—
0
5
(3036489) Thrombin time
9
49
1.88
1.00
2.2
2.5
s
23.1
21.1
—
9
43
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
33
244
1.43
1.00
1.3
1.2
iu/ml
16.1
26.2
—
9
82
(3001019) Free T4 and TSH panel - Serum or Plasma
6
117
0.50
0.98
1.5
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
37
1.93
0.95
4.6
4.5
%
60.9
58.1
—
7
37
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
50
401
1.34
0.94
1.5
1.6
—
—
—
0
0
(3019225) pH of Specimen
15
94
1.65
0.94
3.1
4.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
155
1450
1.38
0.93
4.1
3.4
mmol/l
1.4
1.3
0.36
143
1361
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
63
1.79
0.92
1.8
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
159
1495
1.40
0.91
4.6
3.8
mmol/l
4.6
4.7
0.78
148
1413
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
29
2.10
0.90
1.0
7.7
—
817.6
—
0
5
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
137
1263
1.31
0.88
3.8
3.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14
90
1.60
0.80
3.0
3.9
pmol/l
4.8
4.8
0.03
14
80
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
197
0.63
0.80
1.6
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
30
228
1.38
0.79
1.6
1.2
u/ml
18.5
4.8
—
10
95
(3003327) Ova and parasites identified in Stool by Light microscopy
9
53
1.73
0.76
1.0
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
41
331
1.30
0.74
2.2
2.6
umol/l
363.5
5225.4
1.26
33
292
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
250
1.34
0.72
1.9
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
43
1.65
0.67
1.1
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
157
1492
1.31
0.67
4.4
3.8
mmol/l
1.4
1.4
0.10
146
1403
(3005322) IgE [Units/volume] in Serum or Plasma
14
95
1.51
0.66
1.4
1.3
u/ml
26.9
400.9
0.84
14
84
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
29
1.74
0.64
1.4
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
3.7
—
20.0
—
0
20
(3010813) Leukocytes [#/volume] in Blood
182
1778
1.64
0.60
33.3
16.3
e9/l
6.9
6.6
1.37
174
1728
(3026361) Erythrocytes [#/volume] in Blood
182
1777
1.65
0.60
33.2
16.2
e12/l
4.6
4.6
0.72
176
1730
(4268621)
0
22
0.00
0.59
0.0
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
55
1.47
0.57
3.0
2.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
37
1.64
0.56
4.8
4.2
e9/l
5.5
4.4
—
6
37
(3025941) Bacteria identified in Stool by Culture
14
99
1.45
0.56
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
44
373
1.23
0.54
1.7
1.7
mmol/l
1.5
1.4
0.38
39
322
(3007461) Platelets [#/volume] in Blood
181
1773
1.49
0.47
33.4
16.3
e9/l
261.5
253.0
0.88
175
1730
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
19
148
1.32
0.45
8.6
6.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
176
1.28
0.44
2.2
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
31
1.63
0.43
3.0
2.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
32
1.58
0.42
2.2
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
168
1.28
0.42
1.6
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
79
1.42
0.41
2.7
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
51
451
1.18
0.41
2.0
2.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
4.1
—
2.4
—
0
15
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
137
0.71
0.40
1.2
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
35
1.44
0.39
1.4
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
340
1.19
0.37
2.3
2.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
81
1.38
0.37
1.6
1.1
—
—
—
0
0
(3000492) Spirometry study
20
164
1.25
0.34
1.4
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
272
0.82
0.33
1.5
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
74
1.37
0.33
1.5
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
52
1.36
0.31
1.7
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
93
1.31
0.30
3.2
3.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
112
1.27
0.29
1.1
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
39
348
1.15
0.29
3.9
3.9
mg/mmol
5.9
11.3
0.64
34
231
(3008898) HLA-B27 [Presence]
11
85
1.31
0.28
1.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
314
1.14
0.24
2.4
2.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
37
1.36
0.23
2.0
2.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
40
1.26
0.22
2.2
2.9
umol/l
3.0
5.3
—
5
30
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
10
0.00
0.21
0.0
5.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.9
—
3.2
—
0
12
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
260
1.14
0.21
1.7
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
48
1.26
0.20
1.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
49
1.23
0.20
2.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
2.0
1.5
—
—
—
0
0
(3020891) Body temperature
6
51
1.18
0.19
6.3
4.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
70
0.71
0.17
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
70
0.71
0.17
1.6
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
70
0.71
0.17
1.6
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
70
0.71
0.17
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
233
0.89
0.15
2.3
2.4
ug/l
0.7
0.6
0.14
14
115
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
35
326
1.09
0.13
3.6
3.6
%
22.9
22.1
0.08
16
114
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
144
1.12
0.11
2.1
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
186
0.91
0.09
1.6
1.9
—
—
—
0
0
(4034850)
5
47
1.07
0.09
8.8
8.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
35
332
1.07
0.09
3.3
3.1
mg/l
60.7
70.9
0.08
29
224
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
37
352
1.06
0.08
1.7
1.6
—
—
—
0
0
(1002224) Polysomnography panel
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
104
0.86
0.06
1.0
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
152
0.91
0.06
1.9
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
62
634
0.97
0.05
2.6
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
141
1.07
0.03
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
16
163
0.98
0.00
1.5
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
235
0.98
0.00
1.4
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
25.5
—
0
6
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
8.8
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4035726)
9
92
0.98
0.00
1.3
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
16.7
—
0
7
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.9
—
7.1
—
0
8
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
13.5
—
0
9
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
75
0.93
0.00
1.4
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(4024509)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
57
0.87
0.00
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
120.4
—
0
7
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
54
0.92
0.00
1.2
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
2.6
—
109.9
—
0
8
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
7
0.00
0.00
0.0
28.6
—
98.9
—
0
7
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.8
—
13.7
—
0
9
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
5
54
0.92
0.00
1.4
2.0
—
4.9
—
0
20
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
-0.00
0.0
6.6
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
-0.00
0.0
1.0
—
177.8
—
0
5
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
6.2
—
55.8
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TOXIC_EFFECT_CORROSIVE_SUBST – Toxic effect of corrosive substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).